Back
YieldMax TSLA Option Income Strategy ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
51
TSLY
YieldMax TSLA Option Income Strategy ETF
Last Price:
$40.18
Seasonality Move:
-26.78%
Buy
80
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.73
Seasonality Move:
11.35%
Buy
51
YieldMax TSLA Option Income Strategy ETF (TSLY)
is a Buy
Is YieldMax TSLA Option Income Strategy ETF a Buy, Sell or Hold?
-
The current YieldMax TSLA Option Income Strategy ETF [TSLY] share price is $40.16. The Score for TSLY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
TSLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TSLY Stock Price Chart
What is YieldMax TSLA Option Income Strategy ETF's stock price today?
-
The YieldMax TSLA Option Income Strategy ETF share price today is $40.16Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TSLY is experiencing slight selling pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TSLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.53 | Buy |
| Relative Strength Index (14 RSI): | 53.08 | Buy |
| Chaikin Money Flow: | -169098 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.62 - 39.84) | Buy |
| Bollinger Bands (100): | (38.11 - 43.29) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.77 | Buy |
| Relative Strength Index (14 RSI): | 85.1 | Buy |
| Chaikin Money Flow: | 991653 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (219.01 - 220.61) | Buy |
| Bollinger Bands (100): | (55.63 - 178.69) | Buy |
TSLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.8 | Buy |
| 20-day SMA: | 39.03 | Buy |
| 50-day SMA: | 40.21 | Sell |
| 200-day SMA: | 41.2 | Sell |
| 8-day EMA: | 21.22 | Buy |
| 20-day EMA: | 10.39 | Buy |
| 50-day EMA: | 4.53 | Buy |
| 200-day EMA: | 1.18 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.26 | Buy |
| 20-day SMA: | 220.14 | Buy |
| 50-day SMA: | 161.87 | Buy |
| 200-day SMA: | 73.76 | Buy |
| 8-day EMA: | 220.14 | Buy |
| 20-day EMA: | 210.53 | Buy |
| 50-day EMA: | 173.33 | Buy |
| 200-day EMA: | 94.53 | Buy |
YieldMax TSLA Option Income Strategy ETF Earnings Growth & TSLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
YieldMax TSLA Option Income Strategy ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||